Matthew Perry's assistant gets more than 3 years in prison for central role in his ketamine death

LOS ANGELES (AP) — Matthew Perry's personal assistant was sentenced to three years and five months in prison for his role in the drug death of the “Friends” star. The  60-year-old Kenneth Iwamasa pleaded guilty to conspiracy to distribute ketamine. Perry's family blames Iwamasa, a longtime friend, for enabling Perry's addiction. According to his plea agreement, the assistant bought ketamine on Perry's behalf and injected him with it personally. The actor died at age 54 in 2023. Four other defendants have pleaded guilty and received sentences in the case.

Recommended for you

Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Recommended for you

(0) comments

Welcome to the discussion.

Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.

Thank you for visiting the Daily Journal.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account.

We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.

A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!

Want to join the discussion?

Only subscribers can view and post comments on articles.

Already a subscriber? Login Here